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a b s t r a c t
It has been demonstrated that bone marrow mesenchymal stem cell (BM-MSCs) transplantation has
beneﬁcial effects on several central nervous system (CNS) debilitating conditions. Growing evidence
indicate that trophic factors secreted by these cells are the key mechanism by which they are acting.
These cells are frequently used in combination with 3D artiﬁcial matrices, for instance hydrogels, in
tissue engineering-based approaches. However, so far, no study has been reported on the inﬂuence of
such matrices, namely the presence or absence of extracellular matrix motifs, on BM-MSCs secretome
and its effects in neuronal cell populations. In this sense, we herein studied the impact of a hydrogel,
gellan gum, on the behavior and secretome of BM-MSCs, both in its commercial available form
(commonly used in tissue engineering) and in a ﬁbronectin peptide-modiﬁed form. The results showed
that in the presence of a peptide in the gellan gum hydrogel, BM-MSCs presented higher proliferation
and metabolic activity than in the regular hydrogel. Moreover, the typical spindle shape morphology of
BM-MSCs was only observed in the modiﬁed hydrogel. The effects of the secretome of BM-MSCs were
also affected by the chemical nature of the extracellular matrix. BM-MSCs cultured in the modiﬁed
hydrogel were able to secrete factors that induced higher metabolic viabilities and neuronal cell den-
sities, when compared to those of the unmodiﬁed hydrogel. Thus adding a peptide sequence to the gellan
gum had a signiﬁcant effect on the morphology, activity, proliferation and secretome of BM-MSCs. These
results highlight the importance of mimicking the extracellular matrix when BM-MSCs are cultured in
hydrogels for CNS applications.
 2013 Published by Elsevier Masson SAS.
1. Introduction
Mesenchymal stem cells (MSCs) are particularly appealing for
regenerative medicine applications because they are easy to isolate
and expand, do not pose any serious ethical or technical problems,
and can be used for autologous approaches, without the risk of
tumor formation. MSCs derived from the bone marrow (BM-MSCs)
are perhaps the most widely applied in regenerative approaches,
including cardiac [1], bone [2], neural [3], cartilage [4], lung [5] and
meniscus [6] related applications. In recent years it has been shown
that the possible therapeutic potential of these cells is closely
related to their secretome, which includes growth factors, micro-
vesicles and exosomes to the extracellular milieu [7]. In fact,
several reports have revealed that BM-MSCs secretome can be a
potent regulator of neuronal differentiation and survival [8e10].
However, the low survival rate of BM-MSCs upon trans-
plantation is still a major hurdle regarding their clinical application
for CNS related strategies. One possible route to follow would be
the combination of MSCs with biomaterials through tissue engi-
neering based methodologies. Tissue engineering is an interdisci-
plinary ﬁeld that usually combines cells and biomaterials in order
to restore or improve tissue function [11]. The biomaterial plays a
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central role in any tissue engineering approach and should be
carefully chosen. It is commonly accepted in this ﬁeld that the
biomaterials should be able to act as a substrate for the initial phase
of cell adhesion [12], promote proliferation [13], and temporarily
act as a mechanical support for tissue regeneration [14]. For CNS
related applications hydrogels are particularly compelling because
they can uniformly disperse living cells or drugs into the affected
tissue and have CNS tissue-like mechanical properties [15,16].
Although the combination of BM-MSCs with different hydrogels
has been proposed by others [17e19], the effect of the biomaterial
on the secretome of MSCs has been ignored. As the latter plays a
central role in the therapeutic properties of MSCs, understanding
how the biomaterial modulates MSC secretome is critical.
In the present work we aimed at determining how the modiﬁ-
cation of a hydrogel with an extracellular matrix derived peptide
(GRGDS) could inﬂuence the BM-MSCs morphology, activity and
secretome. For this purpose a linear anionic microbial poly-
saccharide composed of repeating units of glucose, glucuronic acid
and rhamnose named gellan gum (GG) was used [20]. This hydro-
gel, and its derivatives, has previously shown to be favorable for
cartilage and disc repair/regeneration [21,22]. Moreover, it was
previously demonstrated that, by using DielseAlder click chemis-
try, the GRGDS ﬁbronectin-derived peptide could be immobilized
to gellan gum hydrogels and that these peptide-modiﬁed gellan
gum gels promoted greater adhesion and proliferation of neural
stem/progenitors cells (NSPCs) than gellan gum controls [23]. Re-
sults revealed that the presence of the peptide enhanced cell BM-
MSCs proliferation, metabolic activity and cell morphology. More-
over, we also demonstrate that click-conjugated GRGDS-gellan gum
positively modulates the BM-MSCs secretome, which enhanced the
survival and differentiation of primary cultures of hippocampal
neurons in vitro.
2. Materials & methods
2.1. Functionalization of the gellan gum hydrogel with the GRGDS
peptide
The gellan gum hydrogel was modiﬁed with the ﬁbronectin-
derived peptide as previously described [23]. Brieﬂy, gellan gum
(Sigma, USA) was ﬁrst dissolved in 2-(N-morpholino) ethane-
sulfonic acid (MES) buffer (100 mM, pH 5.5) at 37 C. 4-(4,6-
Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
(DMT-MM, Sigma, USA) and furfurylamine (Acros Organics,
Belgium) were then added in a 4:1 M ratio (of each reagent
relative to the eCOOH groups in gellan gum) and stirred at 37 C
for 48 h. The solution was then dialyzed (Mw cutoff 12e14 kDa,
Spectrum Labs, USA) alternately against distilled water and PBS
(0.1 M, pH 7.2) for 5 days. Water was then removed by lyophili-
zation to obtain furan-modiﬁed gellan gum (furan-GG) as a white
powder. Subsequently, the immobilization of maleimide-
containing GRGDS peptide (mal-GRGDS, AnaSpec, USA) to furan-
modiﬁed gellan gum was performed via DielseAlder chemistry
between the maleimide functional group of the peptide with the
furan group of the gellan gum. Furan-GG was ﬁrst dissolved in
MES buffer (100 mM, pH 5.5) at 37 C (4 mg/ml). Mal-GRGDS was
then added in a 5:1 maleimide:furan molar ratio and vigorously
stirred for 48 h at 37 C. The solution was then dialyzed (Mw cutoff
12e14 kDa) alternately against distilled water and PBS (0.1 M, pH
7.2) for 5 days. Finally, the water was removed by lyophilization to
obtain GRGDS-modiﬁed Gellan Gum (GG-GRGDS) as a white
powder. It was previously reported by us that, by using this pro-
tocol, it is possible to obtain a peptide-modiﬁed hydrogel with
approximately 300 nmol of GRGDS peptide covalently bound to
each milligram of gellan gum [23].
2.2. BM-MSCs culture
BM-MSCs, acquired from PROMOCELL (Switzerland), were
cultured in a-MEM (Invitrogen, USA) supplemented with 10% FBS
and 1% antibioticeantimycotic mixture. The culture medium was
changed every 2/3 days. Upon conﬂuence, cells were trypsinized
and passaged to new T75 ﬂasks.
2.3. Cell encapsulation and conditioned medium collection
BM-MSCs were encapsulated in the modiﬁed gellan gum
hydrogel as previously described [24]. Brieﬂy, the gellan gum
powder, either GRGDS-modiﬁed or regular, was dissolved in ultra-
pure water (0.5%, w/v) at 40 C for 1 h. Then, PBS 10was added to
the gel solution in order to start the geliﬁcation process. Cells were
then encapsulated in the hydrogel at the concentration of
5  105 cells/ml. Subsequently, triplicates with 100 ml of hydrogel
each were cultured during 7 days using chambered coverglass
(ThermoScientiﬁc, USA).
After 7 days in culture, the BM-MSCs encapsulated in the
hydrogels were washed 5 times with PBS and then incubated with
neurobasal-A serum-free medium (Invitrogen) for 24 h. Upon
conditioning, the medium was incubated with neuronal primary
cells.
2.4. Hippocampal neuronal cultures
Primary cultures of hippocampal neurons were prepared as
previously described [10]. Brieﬂy, the hippocampi of P4 Wistar rats
were dissected and submitted to trypsin-based enzymatic diges-
tion and mechanical dissociation. Isolated cells were then platted
on poly-D-lysine-coated coverslips at a density of 4  104 cells/cm2
and allowed to grow for 7 days. Then, the neuronal cultures were
incubated with the previously collected conditioned medium for 7
days (with half of the volume of conditioned medium being
renewed at day 4 of culture), after which cell densities, viability and
proliferation were assessed. Besides kanamycin (0.1 mg/ml, Invi-
trogen) and glutamax (1 mM, Invitrogen), no further supplements
were added to the BM-MSCs conditioned medium. Positive control
cultures were kept in neurobasal medium supplemented with
kanamycin, glutamax, bFGF (10 ng/ml, Invitrogen) and B27 (2%,
Invitrogen).
2.5. Metabolic activity assay
Cell metabolic viability was measured using the CellTiter 96
Aqueous One Solution Cell Proliferation Assay (Promega, USA) as
previously described [25]. This assay is based on the bioreduction of
a tetrazolium compound (MTS), into a water-soluble brown for-
mazan product. This conversion is accomplished by NADPH or
NADH production by the dehydrogenase enzymes in metabolically
active cells. Complete culture medium was replaced by standard
basal medium containing MTS in a 5:1 ratio and incubated in a
humidiﬁed atmosphere at 37 C and 5% CO2. After 3 h of incubation,
the optic density for triplicates of each sample (n ¼ 3) was
measured at 490 nm in a microplate reader.
2.6. Proliferation evaluation
The cell proliferation was assessed through double-stranded
DNA quantiﬁcation. Brieﬂy, after cell lysis by osmotic and thermal
shock three components of QuantiTTM PicoGreen dsDNA Assay Kit
(Invitrogen), TriseHCleEDTA (50%), Picogreen dye (35,45%) and cell
lysated (16,35%), were mixed in an opaque 96 well plate. The
ﬂuorescent intensity, proportional to the amount of dsDNA, was
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measured at an excitation wavelength of 485/20 nm and at an
emission wavelength of 528/20 nm, in a microplate reader (Bio-
Tek). The dsDNA concentration for triplicates of each sample (n¼ 3)
was calculated using a standard curve relating quantity of dsDNA
and ﬂuorescence intensity.
2.7. Immunocytochemistry and phalloidin/DAPI staining
The following primary antibodies were used for the immuno-
cytochemical studies: monoclonalmouse anti-GFAP (Chemicon) for
astrocytes and monoclonal mouse anti-MAP2 (SigmaeAldrich) for
neurons. For all immunocytochemical procedures, the appropriate
controls were obtained by omission of the relevant primary anti-
body. Cells on the substrates were ﬁxed with PBS solution con-
taining 4% paraformaldehyde (PFA) for 20 min (on glass) or 1 h (on
the hydrogel) at room temperature and then washed with PBS.
After cell membrane permeation and blocking by treating with 0.3%
Triton X-100 (Sigma, USA) and 10% of FBS solution at room tem-
perature for 1 h, each speciﬁc primary antibody solutionwas added
for 1 h. After washing with 0.5% of FBS in PBS, the samples were
exposed to the speciﬁc secondary antibody (Invitrogen) for 1 h and
thenwashed with 0.5% FBS. Finally, cell nuclei were counterstained
with 1 mg/ml DAPI (Invitrogen) for 10 min.
For the phalloidin/DAPI staining, cells were ﬁxedwith 4% PFA for
30 min at room temperature and then treated with 0.3% Triton X-
100. After PBS washing, 0.1 mg/ml of phalloidin (Sigma) was added
to the cells during 30 min. Finally, cell nuclei were counterstained
with DAPI (1 mg/ml, Invitrogen) for 10 min.
2.8. Statistical analysis
All statistical analyses were performed using GraphPad Prism
version 5.00 for Windows (GraphPad Software, USA). Differences
among groups were assessed by t-test. A p-value of 0.05 (95%
conﬁdence level) was set as the criteria for statistical signiﬁcance.
All data are presented as mean  standard deviation.
3. Results & discussion
In the present work we aimed at understanding if the presence
or absence of an ECM derived peptide on gellan gum hydrogels
could induce changes on the effects caused by BM-MSCs secretome
on hippocampal neuronal cell populations.
BM-MSCs were encapsulated within GRGDS-Gellan Gum
(GRGDS-GG) and compared to BM-MSCs cultured in unmodiﬁed
GG hydrogels. Cell metabolic activity and proliferation were
assessed after 7 days of culture. The results revealed distinct dif-
ferences in BM-MSCs behavior when cultured in the peptide-
modiﬁed hydrogel relative to the unmodiﬁed hydrogel. When
encapsulated in GG-GRGDS, BM-MSCs were able to migrate and
successfully expand throughout the hydrogel; moreover, they
reveal a typical spindle like cell morphology (Fig. 1a). In contrast,
BM-MSCs cultured into the unmodiﬁed GG were unable to expand
and did not present their characteristic morphology (Fig. 1b).
Analysis of the BM-MSCs proliferation also revealed that cells
cultured on GRGDS-modiﬁed hydrogels are able to proliferate to a
signiﬁcantly higher extent (p < 0.05) than cells cultured on un-
modiﬁed hydrogels (Fig. 1c). In addition, the viability of these cells
was also signiﬁcantly higher (p < 0.001) than the viability of cells
grown in the absence of the peptide (Fig. 1d). The higher metabolic
activity may be due to the higher number of cells and not to a direct
effect of the peptide. Nevertheless, it is important to notice that as
previously described by Hutmacher et al., [26] the quantiﬁcation of
metabolic activity in three dimensional cultures byMTS test cannot
be directly compared with proliferations assays, such as the dsDNA
assays. Actually, while the latter are based on the Picogreen assay,
which is a sensitive test that can be correlated with proliferation of
cells with time, MTS relies only in the capability of cells to
Fig. 1. The effect of peptide modiﬁed gellan gum on the morphology, proliferation and activity of BM-MSCs. After 7 days in culture, the cytoskeleton of BM-MSCs cultured on (a)
GRGDS-GG and (b) regular gellanwere stained with phalloidin (red) and nuclei counterstained with DAPI (blue). Cells cultured on peptide modiﬁed hydrogel presented signiﬁcantly
higher (c) proliferation and (d) metabolic activity. Scale bar: 200 mm. Values are shown as mean  standard deviation (n ¼ 3 samples of 5  104 cells/sample, *p < 0.05;
***p < 0.001).
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metabolize MTS into a formazan salt, measuring the metabolic
viability. This metabolic viability cannot be directly compared to
cell proliferation as the cells own basal metabolism may be altered
due to different parameters (such as: porosity, oxygen and nutri-
ents availability, nature of the substrate where they are growing,
etc.) that may or, may not, affect cell proliferation. All together, the
morphological analysis, the proliferation and viability results,
indicate that the behavior of these cells is improved in the presence
of the peptide than the regular gel.
As there are drastic differences on proliferation and cell
morphology, it was hypothesized that there were major differences
on the secretome of the BM-MSCs encapsulated in the native GG
and the modiﬁed GG-GRGDs, as well as its effects on neural cell
populations. In order to test this, conditioned media (CM) obtained
from the BM-MSCs encapsulated in the different forms of GG was
used to culture hippocampal derived cells for seven days, without
the addition of any other supplements. Results revealed that the
proliferation of neuronal cultures was signiﬁcantly higher
(p < 0.05) when cultured in the presence of the BM-MSCs/GRGDS-
modulated CM (Fig. 2b). Similar results were also obtained for cell
metabolic viability. Interestingly, immunocytochemistry analysis
revealed that the secretome derived from BM-MSCs/GGwas unable
to maintain the neurons (MAP-2 positive cells) in culture whereas
the BM-MSCs cultured into the GRGDS-GG were able to secrete
factors that allowed the survival of neuronal cells (Figs. 2d and 3).
The higher proliferation and cell densities obtained probably lead
to an increase of the secreted factors or vesicles, present in the
conditioned media. However, the absence of neurons in the
cultures incubated with the secretome derived from BM-MSCs
encapsulated into the unmodiﬁed gellan gum cannot be
explained solely by the differences in cell number. We previously
demonstrated that in 2D cultures MSCs incubated at 18,750e
125,000 cells/ml were able to secrete factors that promote the
survival of hippocampal neurons [10]. In this study we cultured the
MSCs in 3D at 125,000 cell/ml on day zero allowing them to growth
for 7 days. So, even with a high concentration of cells per milliliter
of culture medium, the MSCs incubated on the unmodiﬁed
hydrogel were unable to condition the medium with secreted fac-
tors in a way that had a positive effect on neurons. In this sense, by
comparing to previously 2D results, we believe that the presence of
the peptide on the hydrogel had a crucial inﬂuence on the factors
secreted by the cells.
As far as we know, there is no literature relating ﬁbronectin-
derived peptides and the secretome of any system. However, it is
well described that the GRGDS peptide binds to integrins on the cell
membrane and enhances cell adhesion and migration [27]. We
believe that the effect of the GRGDS peptide on the secretome is
indirect. Looking to the morphologic differences between the cells
culture in unmodiﬁed and modiﬁed hydrogels, it is expected that
the intracellular machinery of the BM-MSCs is also affected, inﬂu-
encing in this way the factors secreted by the cells. As described by
Martin Schwartz [28] “Integrins receive signals from other re-
ceptors that lead to activation of ligand binding (inside-out
signaling) and matrix assembly. Upon binding ligands, they also
activate intracellular signaling pathways. These signals converse
with pathways that are initiated by soluble ligands to regulate cell
Fig. 2. The effects of BM-MSCs secretome on neuronal cultures. (a) Factors derived from BM-MSCs, cultured either on peptide modiﬁed or regular gellan gum hydrogel, where
incubated with hippocampal neurons for 7 days. The secretome of cells cultured on GRGDS-GG signiﬁcantly promoted higher (b) proliferation, (c) activity and (d) survival of
neuronal cells than the secretome shaped by cells encapsulated on regular gellan gum. Values are shown as mean  standard deviation (n ¼ 3 samples of 1  105 cells/sample,
*p < 0.05; **p < 0.01; ***p < 0.001).
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functions. In this way, cell adhesion is coordinated with other
events to orchestrate complex cellular behavior”. Therefore, the
drastic differences on BM-MSCs’ morphology are expected to have
played a role on the observed results.
Further studies should now focus on characterizing the changes
in the secretome induced by 2D and 3D cultures, using proteomic
based analysis.
4. Conclusions
These results show the importance of chemical cues, namely
those mimicking ECM, within hydrogels in order to adapt BM-MSCs
response and secretome to the desired needs. Indeed by grafting a
ﬁbronectin-based peptide within the hydrogel in which the cells
were cultured, it was possible to positively impact their prolifera-
tion and morphology. The latter had obvious effects on the secre-
tome of BM-MSCs allowing it to better support the survival and
differentiation of hippocampal neurons. Future work will be
focused on the application of GG-GRGDS hydrogel in combination
with BM-MSCs in neuro-regeneration strategies.
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